Brandywine Global Investment Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-443,469
Closed -$6.71M 653
2025
Q3
$6.71M Sell
443,469
-427
-0.1% -$5.29K 0.05% 329
2025
Q2
$5M Buy
+443,896
New +$4.81M 0.04% 373

Other funds holding ROIV

Brandywine Global Investment Management's ROIV Position: Q4 2025 in Review

Brandywine Global Investment Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 443,469 shares — an estimated $6.71M sold.

Brandywine Global Investment Management first reported a position in ROIV in Q2 2025 and held it in 2 quarters. The position peaked at $6.71M in Q3 2025. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Brandywine Global Investment Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Brandywine Global Investment Management sold 443,469 Roivant Sciences shares in Q4 2025, an estimated $6.71M.
  • Brandywine Global Investment Management first reported a position in Roivant Sciences in Q2 2025 and held it in 2 quarters.
  • Brandywine Global Investment Management's Roivant Sciences position peaked at $6.71M in Q3 2025.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.